FDA Approves First Drug Eluting Angioplasty Balloon

The FDA has approved C.R. Bard’s Lutonix 035 Drug Coated Balloon (Lutonix DCB), a technology that may reduce restenosis of vessels treated by balloon angioplasty. This technology is the first of its kind to be approved for use in the femoral and popliteal arteries when they are stricken by Peripheral Artery Disease (PAD).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news